Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

Cardiac disorders – page 25

  • 481 clinical trials
  • 225 recruiting
  • 172 conditions
  • 28 countries

Conditions in this area

172 conditions with trials, the busiest first

Atrial fibrillation55Cardiac failure42Coronary artery disease37Acute myocardial infarction30Cardiac amyloidosis29Acute coronary syndrome21Cardiac arrest19Cardiac failure chronic17Cardiovascular disorder16Heart failure with reduced ejection fraction16Hypertrophic cardiomyopathy16Cardiac failure acute14Glycogen storage disease type II14Heart failure with preserved ejection fraction13Myocardial infarction13Cardiomyopathy11Myocardial ischaemia11Cardiogenic shock10Chronic coronary syndrome10Dilated cardiomyopathy9Myocarditis9Aortic valve stenosis7Chronic kidney disease6Trisomy 216+148

Clinical trials in Cardiac disorders

481 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

481 clinical trials

Heart failure with preserved ejection fraction

Not yet recruiting

Study on the Effects of Dapagliflozin for Patients with Heart Failure with Preserved Ejection Fraction

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Gregorio Maranon

Cardiac function disturbance postoperative+1

Not yet recruiting

Study on Preventing Acute Kidney Injury After Heart Surgery Using Empagliflozin in Patients Undergoing Elective Cardiac Surgery

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Empagliflozin
  • Sponsor:Hospital Clinico Universitario De Valladolid

Cardiac failure acute

Not yet recruiting

Study on Acetazolamide with Empagliflozin and Dapagliflozin for Patients with Acute Heart Failure and Fluid Retention

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Acetazolamide
  • Sponsor:Ziekenhuis Oost Limburg

Myocarditis

Not yet recruiting

Study on Methylprednisolone and Human Normal Immunoglobulin for Treating Fulminant Myocarditis in Patients

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Glucose
  • Sponsor:Assistance Publique Hopitaux De Paris

Myocardial ischaemia

Not yet recruiting

Study on [68Ga]NODAGA-E[c(RGDyK)]2 for Imaging Blood Vessel Growth in Patients with Chronic Ischemic Heart Disease

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:[68GA]NODAGA-GLU(CYCLO[-ARG-GLY-ASP-D-TYR-LYS)]2
  • Sponsor:Region Hovedstaden

Cardiac function disturbance postoperative

Not yet recruiting

Study on Alkaline Phosphatase to Prevent Inflammation and Kidney Injury in Patients Undergoing Open-Heart Surgery

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Alkaline Phosphatase, Bovine
  • Sponsor:Alloksys Life Sciences B.V.

Atrial fibrillation

Not yet recruiting

Study Comparing Dabigatran Etexilate, Acetylsalicylic Acid, and Clopidogrel for Preventing Blood Clots in Patients with Atrial Fibrillation After Heart Procedure

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Centre Hospitalier Universite De Laval

Dyspnoea

Not yet recruiting

Study on Fentanyl and Morphine for Treating Severe Shortness of Breath in Heart Failure Patients

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Fentanyl
  • Sponsor:Fundacio Assistencial De Mutua De Terrassa Fpc

Cardiac failure+2

Not yet recruiting

Study on the Effects of Dobutamine and Levosimendan in Patients with Heart Failure and Reduced Left Ventricular Function

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Levosimendan
  • Sponsor:Instituto De Investigacion En Ciencias De La Salud Germans Trias I Pujol

Chronic kidney disease+3

Not yet recruiting

Study on Dapagliflozin for Patients with Chronic Kidney Disease or Kidney Failure Undergoing Hemodialysis

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Medical University Of Vienna

Atrial fibrillation+1

Not yet recruiting

Title: Evaluation of optimal timing for heparin anticoagulation in patients undergoing transseptal heart procedures (TEER or left atrial appendage closure)

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Heparin Sodium
  • Sponsor:Agencja Badań Medycznych

Heart disease congenital

Not yet recruiting

Study Comparing Custodiol-N and Custodiol for Heart Surgery in Children with Congenital Heart Defects

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Alanine
  • Sponsor:Dr. Franz Koehler Chemie GmbH

Substances studied in this area

The therapies tested most often in Cardiac disorders trials.

Acetylsalicylic Acid44 clinical trialsClopidogrel30 clinical trialsTicagrelor27 clinical trialsSodium Chloride25 clinical trialsDapagliflozin22 clinical trialsApixaban21 clinical trialsEmpagliflozin20 clinical trialsRivaroxaban19 clinical trialsPrasugrel18 clinical trials
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.